Abstract

The development of the Prescription Drug Monitoring Program (PDMP) led to an innovation in the healthcare organization system (HCOs). The PDMP system has been utilized in different states at various organizational levels in an effort to achieve improved health outcomes, reduce the number of prescription drug overdoses, and lighten the economic burden that follows. However, during the implementation of PDMP, there were several barriers and limitations that were discovered. Those barriers impeded the process of utilization of PDMP, such as the complex user interface and lack of training for healthcare providers. The purpose of this paper was to examine the advances and limitations in the utilization and implementation of PDMP in the US healthcare industry and develop strategies for effective use of PDMP in West Virginia.The qualitative part of this paper was a literature review. The paper referred to several peer-reviewed studies and research articles from several reliable resources, which were reached by databases or Google Scholar. A total of 44 articles were reviewed for this study.The implementation of the PDMP was influenced by benefits and barriers. This article reviewed several studies in general that demonstrated positive outcomes from the implementation of PDMP, including a reduced number of prescription drug overdoses, coordinated care for patients, and improved health outcomes. However, the barriers and limitations were not neglected, which mainly include integration of PDMP into the electronic health record (EHR) system, lack of training for the providers, and lack of basic standards for the use of PDMP.Although the new health reforms encouraged the adaption of PDMP among providers, data reporting and data interpretation still remain major concerns for assessing the health outcomes of PDMP implementation.

Highlights

  • BackgroundRules and regulations, new healthcare reforms, and the ever-growing healthcare industry in the United States, highly affect the overall quality of care and health outcomes

  • The present study provides evidence that the use of Prescription Drug Monitoring Program (PDMP) may potentially decrease prescription drug overdoses in the rural West Virginia population and the barriers that need to be overcome

  • The primary purpose of this literature review article was to examine the utilization of the PDMP model in the US healthcare industry and the barriers associated with it

Read more

Summary

Introduction

BackgroundRules and regulations, new healthcare reforms, and the ever-growing healthcare industry in the United States, highly affect the overall quality of care and health outcomes. The overall US spending on healthcare has exceeded $4.1 trillion or 19.7% of the total Gross Domestic Product (GDP), accounting for greater than $12,530 per person, in 2020, which shows an approximate 9.7% increase, as compared to just 4.3% increase seen in 2019 [1]. West Virginia has been noted as one of the top 10 states with the highest age-adjusted drug overdose death rates at 51.5/100,000 standard population [5]. PDMPs typically collect and store the information for the quantity and the type of prescription drug dispensed to the patient, which can be further utilized by the health care providers, How to cite this article Al-Astal A, Sodhi K, Lakhani H (February 21, 2022) Optimization of Prescription Drug Monitoring Program to Overcome Opioid Epidemic in West Virginia. 49 states have taken the initiative for the implementation of the PDMP model, the utilization is still limited by the prescribers [9]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call